{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:03:43Z","timestamp":1788995023542,"version":"build-2803163510"},"reference-count":18,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"not funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.1080\/14656566.2021.1904892","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:26:22Z","timestamp":1616671582000},"page":"1253-1256","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Finerenone \u2013 are we there yet with a non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic chronic kidney disease?"],"prefix":"10.1080","volume":"22","author":[{"given":"Sheila A.","family":"Doggrell","sequence":"first","affiliation":[{"name":"Faculty of Health, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012070718"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-er07"},{"key":"cit0004","first-page":"CD007004","volume":"10","author":"Chung EY","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000091"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.11.021"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051898"},{"key":"cit0009","unstructured":"ClinicalTrials.gov. Efficacy and safety of finerenone in subjects with type 2 diabetes and the clinical diagnosis of diabetic kidney disease (FIGARO-DKD). [cited 2020 Dec 31]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02545049?term=finerenone&draw=2&rank=5"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1159\/000503712"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-0377-6"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06870520"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616011"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30268-7"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31150-X"},{"key":"cit0018","unstructured":"Mann JFE, Hansen T, Idorn T, et al. Effect of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1904892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T11:06:53Z","timestamp":1625742413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1904892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,7,3]]}},"alternative-id":["10.1080\/14656566.2021.1904892"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1904892","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}